FIRST-LINE ADVANCED NSCLC PATIENTS

Clinical trials for FIRST-LINE ADVANCED NSCLC PATIENTS explained in plain language.

Never miss a new study

Get alerted when new FIRST-LINE ADVANCED NSCLC PATIENTS trials appear

Sign up with your email to follow new studies for FIRST-LINE ADVANCED NSCLC PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial offers hope for advanced lung cancer patients

Disease control Recruiting now

This study is testing a new drug called SSGJ-706 for people with advanced non-small cell lung cancer (NSCLC). Researchers want to see how well the drug works and how safe it is, both when given alone and when combined with other treatments. The trial will involve about 240 patien…

Matched conditions: FIRST-LINE ADVANCED NSCLC PATIENTS

Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

FIRST-LINE ADVANCED NSCLC PATIENTS

Get alerted when new FIRST-LINE ADVANCED NSCLC PATIENTS trials appear

New drug trial offers hope for advanced lung cancer patients